| Status: Not endorsed (Statement of Advice) | ||
Micafungin (Mycamine®) is not recommended for use within NHS Wales for the treatment of invasive candidiasis in adults (including the elderly) and children (including neonates). |
||
|
||
Medicine details |
||
| Medicine name | micafungin (Mycamine®) | |
| Formulation | powder for solution for infusion | |
| Reference number | 202 | |
| Indication | Treatment of invasive candidiasis |
|
| Company | Astellas Pharma Ltd | |
| BNF chapter | Infections | |
| Submission type | Full | |
| Status | Not endorsed (Statement of Advice) | |
| Advice number | 0309 | |
| NMG meeting date | 27/01/2009 | |
| AWMSG meeting date | 25/02/2009 | |
| Ratification by Welsh Government | 22/07/2009 | |
| Date of issue | 04/08/2009 | |